Therapies

Home > Therapies

Patient Access

Onyx is committed to helping patients gain access to our therapies.  Through its programs, the company provides patients, caregivers and healthcare providers with coverage and reimbursement support, patient assistance and informational resources.


  • Overview
  • Nexavar ® (sorafenib) Tablets
    • Nexavar ® (sorafenib) Tablets for Advanced Kidney Cancer
      • About Kidney Cancer
      • Resources
    • Nexavar ® (sorafenib) Tablets for Unresectable Liver Cancer
      • About Liver Cancer
      • Resources
    • Patient Access
      • REACH® for Nexavar
  • Kyprolis ® (carfilzomib) for Injection
    • Patient Access
      • Onyx Pharmaceuticals 360™ (Onyx 360)
  • Patient Access
    • REACH® for Nexavar
    • Onyx Pharmaceuticals 360™ (Onyx 360)
  • Home
  • About Us
    • Overview
    • Historical Timeline
    • Executive Team
    • Board of Directors
    • Corporate Responsibility
    • Corporate Values
    • Partnering with Onyx
    • Awards and Recognitions
    • Contact Us
  • Therapies
    • Overview
    • Nexavar ® (sorafenib) Tablets
    • Kyprolis ® (carfilzomib) for Injection
    • Patient Access
  • Clinical Development
    • Overview
    • Clinical Pipeline
    • Sorafenib
    • Carfilzomib
    • Oprozomib
    • ONX 0914
    • Palbociclib
    • Investigator Sponsored Trials
  • Investors
    • Overview
    • Event Calendar
    • Analyst Coverage
    • SEC Filings
    • Financial Information
    • Stock Information
    • Annual Report
    • Proxy Materials
    • Corporate Governance
    • Information Request
  • News & Media
    • Overview
    • Press Releases
    • Online Media Kit
  • Careers
    • Overview
    • Job Openings
    • Benefits
    • How to Apply
  • Contact Us
  • Site Map
© Onyx 2013    
  • Terms of Use
  • Home
  • About Us
    • Overview
    • Historical Timeline
    • Executive Team
    • Board of Directors
    • Corporate Responsibility
    • Corporate Values
    • Partnering with Onyx
    • Awards and Recognitions
    • Contact Us
  • Therapies
    • Overview
    • Nexavar ® (sorafenib) Tablets
    • Kyprolis ® (carfilzomib) for Injection
    • Patient Access
  • Clinical Development
    • Overview
    • Clinical Pipeline
    • Sorafenib
    • Carfilzomib
    • Oprozomib
    • ONX 0914
    • Palbociclib
    • Investigator Sponsored Trials
  • Investors
    • Overview
    • Event Calendar
    • Analyst Coverage
    • SEC Filings
    • Financial Information
    • Stock Information
    • Annual Report
    • Proxy Materials
    • Corporate Governance
    • Information Request
  • News & Media
    • Overview
    • Press Releases
    • Online Media Kit
  • Careers
    • Overview
    • Job Openings
    • Benefits
    • How to Apply
  • Glossary
  • Twitter